In eight hepatoma cells, CXCR6 and its ligand CXCL16 are consistently expressed, and elevated expression of CXCR6 promotes HCC invasiveness and is associated with poor outcomes of patients [31]. The gene discussed is CXCL16; the disease is hepatocellular carcinoma.